Export

Pegaspargase
Essential medicine status
General description

INN
Pegaspargase
Medicine type
Biological agent
EML status history
First added in 2019 (TRS 1021) for Lymphoid leukaemia, NOS
Therapeutic equivalent for
Wikipedia
Recommendations
Section
Cytotoxic medicines
  • Parenteral > General injections > IV: 3750 units per 5 mL in vial